ANETUMAB CORIXETAN THORIUM TH-227
UNII 22OG9ZC9MN

Substance Identification & Data

This profile provides standardized clinical and technical data for Anetumab Corixetan Thorium Th-227, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 22OG9ZC9MN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2222980-98-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

22OG9ZC9MN

CAS Registry Number

2222980-98-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANETUMAB CORIXETAN THORIUM TH-227

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C155977

National Cancer Institute reference terminology for clinical and research data.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anetumab Corixetan Thorium Th-227. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANETUMAB CORIXETAN THORIUM TH-227

IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN MONOCLONAL MF-T-IGG1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MF-T-IGG1 .LAMBDA.-CHAIN, DIMER, N6-(4-((4-(3-(BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)-2-((BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)METHYL)PROPYL)PHENYL)AMINO)-1,4-DIOXOBUTYL)-L-LYSINE COMPLEX WITH THORIUM-227TH

Technical Codes

BAY2287411

BAY-2287411

External Clinical & Regulatory Resources

Previous UNII22OAC2MO2S

Next UNII22OVJ6712M